Eprosartan Mesylate
Who holds supplier records for Eprosartan Mesylate? 6 organisations hold a current record for Eprosartan Mesylate: an active US FDA Type II Drug Master File. A further 4 organisations have only historical (inactive) DMF filings. Recorded organisation countries for current records: India (5) and China (1).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records
Cite as: PharmaTek, “Eprosartan Mesylate: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/eprosartan-mesylate
Reading the evidence
- 6 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
5 of the 6 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 3 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (6)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Eprosartan Mesylate. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Dishman Carbogen Amcis LimitedIndiaActive DMF 18155 · latest filing Mar 2005
- GLOCHEM INDUSTRIES LTDIndiaActive DMF 23790 · latest filing Apr 2010
- Hetero Drugs LimitedIndia Company GMP cert on recordActive DMF 23274 · latest filing Nov 2009
- JUBILANT BIOSYS LTDIndiaActive DMF 22863 · latest filing Aug 2009
- Unichem Laboratories Ltd.India Company GMP cert on recordActive DMF 23834 · latest filing Jun 2010
- Zhejiang Huahai Pharmaceutical Co., Ltd.China Company GMP cert on recordActive DMF 26230 · latest filing Jun 2012
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Historical records (4)
Organisations whose Type II DMFs for Eprosartan Mesylate are no longer active. These show a past filing, not current supply.
Show all 4 historical records
- MYLAN LABORATORIES LTDInactive DMF 24009 · filed Jul 2010
- LONZA AGInactive DMF 18079 · filed Feb 2005
- LONZA LTDInactive DMF 16790 · filed Aug 2003
- DISHMAN PHARMACEUTICALS AND CHEMICALS LTDInactive DMF 16703 · filed Jul 2003
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Eprosartan Mesylate is an angiotensin II receptor antagonist used to treat high blood pressure. It functions by blocking the action of angiotensin II, thereby relaxing blood vessels and allowing blood to flow more easily.
Chemical identity
- IUPAC name
- 4-[[2-butyl-5-[(E)-2-carboxy-3-thiophen-2-ylprop-1-enyl]imidazol-1-yl]methyl]benzoic acid;methanesulfonic acid
- Canonical SMILES
- CCCCC1=NC=C(N1CC2=CC=C(C=C2)C(=O)O)/C=C(\CC3=CC=CS3)/C(=O)O.CS(=O)(=O)O
- InChIKey
- DJSLTDBPKHORNY-XMMWENQYSA-N
- Synonyms
- Teveten API, eprosartan mesilate, eprosartan monomethanesulfonate, sk&f 108566-j, sk&f-108566-j, teveten
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Eprosartan Mesylate?
6 organisations hold an active US FDA Type II Drug Master File or a CEP for Eprosartan Mesylate: Dishman Carbogen Amcis Limited (India), GLOCHEM INDUSTRIES LTD (India), Hetero Drugs Limited (India), JUBILANT BIOSYS LTD (India), Unichem Laboratories Ltd. (India) and Zhejiang Huahai Pharmaceutical Co., Ltd. (China). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Eprosartan Mesylate Drug Master Files are active?
Dishman Carbogen Amcis Limited (DMF 18155), GLOCHEM INDUSTRIES LTD (DMF 23790), Hetero Drugs Limited (DMF 23274), JUBILANT BIOSYS LTD (DMF 22863), Unichem Laboratories Ltd. (DMF 23834) and Zhejiang Huahai Pharmaceutical Co., Ltd. (DMF 26230). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Eprosartan Mesylate records mean?
4 organisations have only inactive Type II DMFs for Eprosartan Mesylate. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
How do I qualify a Eprosartan Mesylate supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Eprosartan Mesylate?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.